Induced  pluripotent stem cells for development of cancer immunotherapy - A viable idea for less toxic treatment

Prof. Binafsha Manzoor Syed

doi:10.38106/LMRJ.2022.4.2-01

Induced pluripotent stem cells for development of cancer immunotherapy - A viable idea for less toxic treatment

Authors

Prof. Binafsha Manzoor Syed

DOI:

https://doi.org/10.38106/LMRJ.2022.4.2-01

Keywords:

Cancer management, induced pleuripotent stem cells, monoclonal antibodies

Abstract

Induced pluripotent stem cells were introduced by Prof. Yamanaka and now being studied in all stem cells related treatment methods. Cancer immunotherapy is now part of targeted therapy and showing promising results, however the cost of treatment and tagged risk of side effects making it difficult for patients. Thus use of induced pluripotent stem cells to grow into plasma cells and produce antibodies against cancer targets will be a breakthrough in cancer management

Downloads

Published

2022-06-29

How to Cite

Syed, P. B. M. (2022). Induced pluripotent stem cells for development of cancer immunotherapy - A viable idea for less toxic treatment. LIAQUAT MEDICAL RESEARCH JOURNAL, 4(2). https://doi.org/10.38106/LMRJ.2022.4.2-01

Download Citation

Issue

Vol. 4 No. 2 (2022): Liaquat Medical Research Journal Volume 4 issue 2

Section

Editorial

License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright: Open access journal copyright lies with authors and protected under CC BY-NC-ND 4.0 licence (https://creativecommons.org/licenses/by-nc-nd/4.0/).